Zydus Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TAMSULOSIN HYDROCHLORIDE USP, with a corresponding US DMF Number 17688.
Remarkably, this DMF maintains an Active status since its submission on September 17, 2004, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 04, 2014, and payment made on March 27, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II